Increased sensitivity of mitochondrial respiration to inhibition by nitric oxide in cardiac hypertrophy

Journal of Molecular and Cellular Cardiology

Volumn 33, Issue 1, 2001, Pages 69-82

  Brookes, Paul S ^a,c   Zhang, Junxuan ^a   Dai, Lijun ^a,c   Zhou, Fen ^b,c   Parks, Dale A ^b,c   Darley Usmar, Victor M ^a,c   Anderson, Peter G ^a,c  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Bioenergetics; Cardiac hypertrophy; Congestive heart failure; Mitochondria; Nitric oxide; Threshold

Indexed keywords

CYTOCHROME C OXIDASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE);

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; ENZYME INHIBITION; HEART MITOCHONDRION; HEART VENTRICLE HYPERTROPHY; MALE; MITOCHONDRIAL RESPIRATION; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0035146387     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.2000.1276     Document Type: Article

References (53)

1. Cardiomyopathy of overload. A major determinant of prognosis in congestive heart failure
2. The prognostic role of left ventricular hypertrophy in patients with or without coronary artery disease
3. Left ventricular hypertrophy: Effect on survival
4. Is cardiac failure a consequence of decreased energy reserve?
5. Increased ischemic injury but decreased hypoxic injury in hypertrophied rat hearts
6. Preischemic glycogen reduction or glycolytic inhibition improves postischemic recovery of hypertrophied rat hearts
7. Contribution of oxidative metabolism and glycolysis to ATP production in hypertrophied hearts
8. Cardiac hypertrophy: From fetal to fatal?
9. Superior recovery of hypertrophied rat myocardium after cardioplegic arrest
10. Recovery after cardioplegia in the hypertrophic rat heart
11. Transmural progression of morphologic changes during ischemic contracture and reperfusion in the normal and hypertrophied rat heart
12. Is the failing heart energy depleted?
13. Heart failure: Is there an energy deficit contributing to contractile dysfunction?
14. Electron transport and mitochondria
15. Mitochondria and sarcoplasmic reticulum function in cardiac hypertrophy and failure
16. Normal myocardial function and energetics in volume-overload hypertrophy in the cat
17. Changes in ultrasturcture and respiratory control in mitochondria of rat heart hypertrophied by exercise
18. Hypertrophied non-failing rat heart: Partial biochemical characterization
19. Ischaemia-reperfusion induced alterations of mitochondrial function in hypertrophied rat heart
20. Mitochondrial biogenesis during pressure overload induced cardiac hypertrophy in adult rats
21. Synthesis and degradation of mitochondrial components in hypertrophied rat heart
22. Metabolic enzyme response in the pressure-overloaded heart of weanling and adult rats
23. Mitochondrial function in canine experimental cardiac hypertrophy
24. Coordination of nuclear and mitochondrial gene expression during the development of cardiac hypertrophy in rats
25. Recovery of glycolysis and oxidative metabolism during postischemic reperfusion of hypertrophied rat hearts
26. Reversible inhibition of cyto chrome c oxidase, the terminal enzyme of the mitochondrial respiratory chain, by nitric oxide. Implications for neurodegenerative diseases
27. Expression of inducible nitric oxide synthase in failing and nonfailing human heart
28. Expression of inducible nitric oxide synthase fin human heart failure
29. Increased peroxynitrite during ischemia and reperfusion in hypertrophied rat hearts
30. Metabolic control analysis and threshold effect in oxidative phosphorylation: Implications for mitochondrial pathologies
31. 2 consumption in the nonhuman primate: An additional mechanism of action of amlodipine
32. Energy thresholds in brain mitochondria. Potential involvement in neurodegeneration
33. Threshold effect and tissue specificity. Implication for mitochondrial cytopathies
34. Cleavage of structural proteins during the assembly of the head of bacteriophage
35. Biochemical properties of subsarcolemmal and interfibrillar mitochondria isolated from rat cardiac muscle
36. Protein measurement with the Folin phenol reagent
37. Citrate synthase from rat liver
38. Subfractionation of mitochondria and isolation of the proteins of oxidative phosphorylation
39. Defenition of cytochrome c binding domains by chemical modification
40. Inhibition of cytochrome c oxidase in turnover by nitric oxide: Mechanism and implications for control of respiration
41. Canine myocardial ischemia: Defect in mitochondrial electron transfer complex I
42. The regulation of mitochondrial oxygen uptake by redox reactions involving nitric oxide and ubiquinol
43. Nitric oxide produced by activated astrocytes rapidly and reversibly inhibits cellular respiration
44. Endogenous endothelial nitric oxide synthase-derived nitric oxide is a physiological regulator of myocardial oxygen consumption
45. Biological aspects of reactive nitrogen species
46. 2 transport in normal and hypertrophied hearts
47. On the mechanism of inhibition of cytochrome c oxidase by nitric oxide
48. The peroxynitrite reductase activity of cytochrome c oxidase involves a two-electron redox reaction at the heme a3-CuB site
49. Differential inhibitory action of nitric oxide and peroxynitrite on mitochondrial electron transport
50. Peroxynitrite inhibits leukocyte-endothelial cell interactions and protects against ischemia-reperfusion injury in rats
51. The formation of nitric oxide donors from peroxynitrite
52. Peroxynitrite irreversibly decreases diastolic and systolic function in cardiac muscle
53. Peroxynitrite impairs cardiac contractile function by decreasing cardiac efficiency